All data are based on the daily closing price as of June 27, 2025
t
Towa Pharmaceutical
4553.TSE
20.73 USD
-0.08
-0.38%
Overview
Last close
20.73 usd
Market cap
1.02B usd
52 week high
22.81 usd
52 week low
16.24 usd
Target price
28.2 usd
Valuation
P/E
7.7579
Forward P/E
16.7785
Price/Sales
0.5676
Price/Book Value
0.8585
Enterprise Value
2.30B usd
EV/Revenue
1.2822
EV/EBITDA
6.9263
Key financials
Revenue TTM
1.79B usd
Gross Profit TTM
654.84M usd
EBITDA TTM
299.61M usd
Earnings per Share
2.67 usd
Dividend
0.48 usd
Total assets
3.16B usd
Net debt
1.24B usd
About
Towa Pharmaceutical Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells ethical drugs, active pharmaceutical ingredients, and intermediates in Japan. The company provides its products in the therapeutic areas of digestive system, nervous system, and allergic diseases, as well as vitamins, antibiotics, and oncology products. It also offers IT service related to healthcare; and disease risk testing services. In addition, the company is involved with research and development of diagnostic drugs; and planning, development and OEM manufacturing of health food, pharmaceuticals, general food and other products. The company was founded in 1951 and is headquartered in Osaka, Japan.